Lumefantrine
An antimalarial fluorene.
![Structure image - Lumefantrine](/data/images/643.png)
CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
In silico identification of drug candidates against COVID-19
3CLpro RdRpol |
in silico | 2.11 | Predicted to inhibit the SARS-CoV-2 3C-like protease. |
Oct/20/2020 |
AI-suggested references
Clinical trials
ID | Title | Status | Phase | Start date | Completion date |
---|---|---|---|---|---|
NCT04695197 | Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso | Recruiting | Phase 3 | Jan/08/2021 | Jul/31/2023 |
|